Cancer Drug Development Forum asbl
Registered office: c/o BLSI, Clos Chapelle-aux-Champs 30, 1200 Woluwe Saint Lambert, Belgium
Register of legal entities: the French Speaking Enterprise Court in Brussels
Enterprise number: 738.523.752
Privacy Policy
info@cddf.org
Tel: +32 2 880 62 70
The CDDF multi-stakeholder workshop on Dose Optimization in Early Oncology Drug Development (3-4 April 2023, Amsterdam) generated lots of interest and fruitful discussion among meeting attendees from various backgrounds.
📺 To watch the interviews with the participants who shared their unique views on the CDDF multi-stakeholder discussion on dose optimization, click the following link: https://youtu.be/K7i3zyN7Fc4
🎙 Interviewees: Filip Josephson (MPA,SE), Benoy Daniel (Medicines and Healthcare products Regulatory Agency, UK), Lisa Vervueren (NIHDI, BE), Divya Samineni (Roche, US), and Stefan Symeonides (Edinburgh Cancer Research Centre, UK)
🔔 COLLABORATION IS KEY TO IMPROVING CANCER TREATMENT!